+49 30 648 35 164 service@chameleon-pharma.com

South Africa

Two giraffes in the Kruger National parc in South Africa

Featured image: Photo by Tobin Rogers on Unsplash

The OTC and pharma market in South Africa

According to CPC’s projections, South Africa’s phar­ma­ceu­ti­cal mar­ket is expected to increase at a CAGR of 5.8% from 2012 to 2020, by which time its value will have risen in value from US $3.61 bil­lion to US $5.1 bil­lion. This expected fast growth will be dri­ven by the government’s health­care reforms, which include improv­ing access to health­care ser­vices by expand­ing National Health Insur­ance (NHI) cov­er­age to the entire South African pop­u­la­tion, and over­haul­ing the nation’s drug reg­u­la­tory processes to make them faster and more trans­par­ent. These moves, together with the intro­duc­tion of a new reg­u­la­tory agency and efforts to aug­ment eco­nomic growth, will advance the country’s phar­ma­ceu­ti­cal sec­tor and boost for­eign invest­ment.

South Africa is also mod­ernising its reg­u­la­tory struc­ture to speed up drug approvals and increase for­eign invest­ment in the coun­try. Under the old reg­u­la­tory regime, drug approvals took a long time and the process was not trans­par­ent, and this led many Pharma multi-­na­tion­als to con­sider invest­ing in other mar­kets where there was greater clar­ity, more stream-­lined processes, and less risk. To this end, the gov­ern­ment is estab­lish­ing the South African Health Prod­ucts Reg­u­la­tory Agency (SAHPRA) to replace the Med­i­cines Con­trol Coun­cil (MCC). The new body will have a wide range of respon­si­bil­i­ties, includ­ing chipping away at the country’s back­log of drug appli­ca­tions and speeding up the reg­is­tra­tion process from its current five years to one year.


South Africa in numbers

Total population


Population growth

Birth rate

Mortality rate

Life expectancy

Interested in this market?

We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.

Our services


International Strategy & Analysis

Licensing and

International Business & Market Entry

Pharma Regulatory & Registration


Product Potential & Country Analysis

Pharma Executive

International Company Partner Identification

Market Reports and Analysis